Credit Suisse’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,208
| Closed | -$21K | – | 3541 |
|
|
2021
Q4 | $21K | Sell |
1,208
-5,939
| -83% | -$103K | ﹤0.01% | 3591 |
|
|
2021
Q3 | $154K | Buy |
7,147
+261
| +4% | +$5.62K | ﹤0.01% | 3421 |
|
|
2021
Q2 | $241K | Buy |
6,886
+40
| +0.6% | +$1.4K | ﹤0.01% | 3362 |
|
|
2021
Q1 | $675K | Sell |
6,846
-2,403
| -26% | -$237K | ﹤0.01% | 2783 |
|
|
2020
Q4 | $1M | Sell |
9,249
-6,995
| -43% | -$759K | ﹤0.01% | 2578 |
|
|
2020
Q3 | $1.67M | Buy |
16,244
+6,333
| +64% | +$653K | ﹤0.01% | 1930 |
|
|
2020
Q2 | $2.07M | Buy |
9,911
+4,799
| +94% | +$1M | ﹤0.01% | 1832 |
|
|
2020
Q1 | $500K | Sell |
5,112
-4,083
| -44% | -$399K | ﹤0.01% | 2528 |
|
|
2019
Q4 | $1.06M | Buy |
9,195
+7,975
| +654% | +$919K | ﹤0.01% | 2464 |
|
|
2019
Q3 | $66K | Buy |
1,220
+19
| +2% | +$1.03K | ﹤0.01% | 3335 |
|
|
2019
Q2 | $143K | Sell |
1,201
-45
| -4% | -$5.36K | ﹤0.01% | 3259 |
|
|
2019
Q1 | $65K | Sell |
1,246
-51
| -4% | -$2.66K | ﹤0.01% | 3293 |
|
|
2018
Q4 | $41K | Buy |
+1,297
| New | +$41K | ﹤0.01% | 3272 |
|
|
2018
Q3 | – | Sell |
-1,557
| Closed | -$82K | – | 3279 |
|
|
2018
Q2 | $82K | Buy |
+1,557
| New | +$82K | ﹤0.01% | 3393 |
|
|
2017
Q1 | – | Sell |
-1,198
| Closed | -$35K | – | 3410 |
|
|
2016
Q4 | $35K | Sell |
1,198
-267
| -18% | -$7.8K | ﹤0.01% | 3684 |
|
|
2016
Q3 | $60K | Sell |
1,465
-3,505
| -71% | -$144K | ﹤0.01% | 3654 |
|
|
2016
Q2 | $157K | Buy |
4,970
+3,920
| +373% | +$124K | ﹤0.01% | 3644 |
|
|
2016
Q1 | $54K | Sell |
1,050
-978
| -48% | -$50.3K | ﹤0.01% | 3580 |
|
|
2015
Q4 | $193K | Buy |
2,028
+603
| +42% | +$57.4K | ﹤0.01% | 3678 |
|
|
2015
Q3 | $117K | Sell |
1,425
-2,496
| -64% | -$205K | ﹤0.01% | 3858 |
|
|
2015
Q2 | $637K | Buy |
3,921
+1,692
| +76% | +$275K | ﹤0.01% | 3279 |
|
|
2015
Q1 | $904K | Buy |
2,229
+203
| +10% | +$82.3K | ﹤0.01% | 2806 |
|
|
2014
Q4 | $1.09M | Buy |
+2,026
| New | +$1.09M | ﹤0.01% | 2730 |
|